PSID on ALERT, ADD PositiveID, Corp (OTCQB: PSID) to your watchlist!
There are many reasons why: Research analysts have come up with targets of .48 to .55. Some of those analyst targets make our toes curl from what we are told. In our own research we have found that Revenue is rising from near-zero to maybe 6M this year. That’s a multi-bagger right there. PSID is trading below 12-month sales and full of opportunity and it’s knocking at our door! PSID is the company with virus detection systems developed in league with the Pentagon.
All it takes is the right headline to unlock that story or newest company milestone can be a catalyst, or Maybe it’s other guys chattering about PSID. All I know is that as eager as PSID is to break thru resistance, you can’t wait for the opening bell to get here soon enough.
Let’s keep this short and sweet. Load the chart for PSID and First thing you’ll notice is how PSID has spent the last week punching through the YTD upper trend and Normally this kind of long strong triangle is a coiled spring, too tempting to ignore, but this one is already churning the waters.
Maybe PSID has already technically busted out, in which case that upper trend converts into the new floor and the action keeps moving. If so, it’s early stages. If not, don’t you want to be in position when it does? Because those of you who remember PSID from the Ebola crisis, know this is the company with the virus detection systems.
Do the math; a run from its current level to anywhere near the .48 target given to it yesterday in the SeeThruEquity: Feb 17, 2015 Report would be enormous.
As I said at the start, no matter how you look at PSID this morning it’s exciting and it looks awesome. Now let’s get into some of those recent highlights I mentioned at the top:
PositiveID Corporation (PSID)
Analyst Reports:
Company Website:
Quote:
PSID develops proprietary molecular diagnostic systems for bio-threat detection and rapid medical testing, as well as fully automated pathogen detection systems and assays to detect a range of biological threats at high-value locations.
The Company has two key product lines:
- The M-BAND (Microfluidic Bio-agent Autonomous Networked Detector) system, an airborne bio-threat detection system developed for the homeland defense industry.
- The Firefly Dx, a real-time handheld polymerase chain reactor (PCR) automated pathogen detection system that can be used in the field to detect biological threats without the use of bulky lab equipment.
PSID has a strong IP portfolio protecting its 2 products; which includes 20 patents and patents pending and an expanding portfolio.
1) One of PSID’s flagship products was developed under contract with the US Department of Homeland Security, Science & Technology directorate, which included $30 Mln of contract funding.
2) PSID has major contracts: According to a third party analyst, PSID has agreements with large government and commercial partners including The Boeing Company, Leidos, United Technologies Aerospace Systems, Department of Defense, Department of Homeland Security,NASA, ENSCO, and others.
- Boeing paid 2.5Mln Dlrs to PSID in a License and Teaming Agreement.
- PSID received 1 Mln Dlrs for a Department of Defense contract with United Technologies to support the JUPITR program.
3) Two direct competitors were recently bought out, one by Roche and the other by BioMérieux.Each purchase was 450Mln Dlrs.
PSID’s current market cap is 2.87Mln Dlrs… do that math; the potential from the buyout perspective could be astronomical.
4) In 2014, PSID reported revenue for the first time since it began research and development in 2011. For the first 9 months it reported 745K, which is nice but it is not the important part… this month the Company released its 2015 revenue guidance of $3-6 Mln.
In other words, 2015 is expected to be PSID’s breakout year.
Get Ready for a Day Of Potential Profits and PSID is itching to make a more convincing move this week rocking the headlines again when PSID was soaring 3 digits on big waves of fear.
What’s important for us is how PSID has been trying to remember where it “should” trade, and .48 to .55 is a target many research analysts have given to PSID.
We have our eyes feasting on PSID, the boards maybe ramping up with consistent chatter, and rumors of news rampant, and for this reason is why trading on rumors and selling on news works for many investors, get in before the run. Many times rumors are true and News comes and Holders Regret While Sellers Celebrate.
Highlights for PSID
• Last Year PSID saw large gains from the current .02 level; can we see a repeat this year?
• PSID has been punching through the YTD upper trend.
• Analyst’s targets are looking attractive. Some of those targets
• Revenue is could be going from being near nothing to maybe 6M this year.
This is exactly the type of trade we look for pre-market for our portfolio, with a possible volume Surge at open. Once again put PSID on your watch list as highly Urgent, and don’t miss the profits.
As always remember do your own research and lock profits when you have it, our personal trading philosophy. GLTA
Did you know #PhoHouseDallas Franchise is opening Two New Locations and Investors stock ticker is #SAMP which... http://fb.me/7qjeiSlx4
ReplyDelete